XML 33 R18.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY (Unaudited)
12 Months Ended
Jul. 31, 2024
Condensed Financial Information Disclosure [Abstract]  
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY (Unaudited)

NOTE 10 — CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY (Unaudited)

 

The Company performed a test on the restricted net assets of its consolidated subsidiaries in accordance with Rule 4-08(e)(3) of Regulation S-X promulgated by the SEC, “General Notes to Financial Statements” and concluded that it was applicable and the Company is required to disclose the required financial statement information for the parent company.

 

The subsidiaries did not pay any dividends to the parent during the periods presented. For the purpose of presenting parent only financial information, the Company records its investment in its subsidiaries under the equity method of accounting. Such investments are presented on the separate parent only balance sheets as “investment in subsidiaries” and the income (loss) of the subsidiaries is presented as “share of income (loss) of subsidiaries.” Certain information and footnote disclosures generally included in financial statements prepared in accordance with U.S. GAAP have been condensed or are not required.

 

PARENT COMPANY BALANCE SHEET

          
   July 31,  July 31,
   2024  2023
       
ASSETS          
Cash  $14,621   $66,553 
Prepaid expense   1,820    1,750 
Receivable from subsidiaries       29,487 
Investment in subsidiaries   781,661    95,889  
Total Assets  $798,102   $193,679 
           
           
LIABILITIES          
Accounts payable and other accrued liabilities  $54,000   $241,579 
Payable to subsidiaries   312,416     
Due to related parties   2,271    223,041 
Total liabilities   56,271    464,620 
           
Stockholders’ equity          
Series A Preferred stock, $0.0001 par value; 80,000 shares authorized; 0 and 80,000 shares issued and outstanding as of July 31, 2024 and 2023, respectively       8 
Series B Preferred stock, $0.0001 par value; 80,000 shares authorized; 80,000 and 0 shares issued and outstanding as of July 31, 2024 and 2023, respectively   8     
Undesignated preferred stock, $0.0001 par value; 19,920,000 shares authorized; no shares issued and outstanding        
Common stock, $0.0001 par value, 100,000,000 shares authorized; 14,781,803 and 5,903,481 shares issued and outstanding as of July 31, 2024 and 2023, respectively   1,478    590 
Additional paid-in capital   962,416    4,982 
Accumulated deficit   (222,071)   (276,521)
Total stockholders’ equity   741,831    (270,941)
           
Total Liabilities and Stockholders’ Equity  $798,102   $193,679 

 

PARENT COMPANY STATEMENT OF OPERATIONS

          
   For the year ended July 31,
   2024  2023
       
EXPENSE:          
General and administrative  $(401,354)  $(207,297)
           
OTHER INCOME (EXPENSE)          
Gain (loss) from investment in subsidiaries   502,834    (133,913)
Other (expense) net   (47,030)    
Total other income   455,804    (133,913)
           
Net income (loss)  $54,450   $(341,210)

 

PARENT COMPANY STATEMENT OF CASH FLOWS

          
   For the year ended July 31,
   2024  2023
       
Cash flows from operating activities:          
Net income (loss)  $54,450   $(341,210)
Adjustments to reconcile net income to net cash provided by operating activities:          
Share of (gain) loss from investment in subsidiaries   (502,834)   133,913 
Change in operating assets and liabilities:          
Prepaid expense and other assets   (70)   1,500 
Accounts payable and other accrued liabilities   36,623    117,651 
Net cash (used in) operating activities   (411,831)   (88,146)
           
Cash flows from financing activities:          
Proceeds received from private offerings   513,213     
Operating expenses directly paid for subsidiary       (29,487)
Repayment working capital advance from related party       (30,000)
Working capital advance from related party   342,042     
Capital contribution received       210,000 
Deferred offering costs incurred   (495,356)    
Net cash provided by financing activities   359,899    150,513 
           
Net (decrease) increase in cash and cash equivalents   (51,932)   62,367 
Cash and cash equivalents at beginning   66,553    4,186 
Cash and cash equivalents at ending  $14,621   $66,553